BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enaud R, Hooks KB, Barre A, Barnetche T, Hubert C, Massot M, Bazin T, Clouzeau H, Bui S, Fayon M, Berger P, Lehours P, Bébéar C, Nikolski M, Lamireau T, Delhaes L, Schaeverbeke T. Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances. J Clin Med 2019;8:E645. [PMID: 31083321 DOI: 10.3390/jcm8050645] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Beaufils F, Mas E, Mittaine M, Addra M, Fayon M, Delhaes L, Clouzeau H, Galode F, Lamireau T, Bui S, Enaud R. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis. J Clin Med 2020;9:E4080. [PMID: 33348735 DOI: 10.3390/jcm9124080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Thavamani A, Salem I, Sferra TJ, Sankararaman S. Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis. Metabolites 2021;11:123. [PMID: 33671639 DOI: 10.3390/metabo11020123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 van Dorst JM, Tam RY, Ooi CY. What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? Nutrients 2022;14:480. [DOI: 10.3390/nu14030480] [Reference Citation Analysis]
4 Putignani L, Gasbarrini A, Dallapiccola B. Potential of multiomics technology in precision medicine. Curr Opin Gastroenterol 2019;35:491-8. [PMID: 31464810 DOI: 10.1097/MOG.0000000000000589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
5 Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, Delhaes L. The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks. Front Cell Infect Microbiol 2020;10:9. [PMID: 32140452 DOI: 10.3389/fcimb.2020.00009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 41.0] [Reference Citation Analysis]
6 Roda J, Maia C, Almeida S, Oliveira RC, Ferreira R, Oliveira G. Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study. bmjpo 2022;6:e001422. [DOI: 10.1136/bmjpo-2022-001422] [Reference Citation Analysis]
7 Xiong W, Huang J, Li X, Zhang Z, Jin M, Wang J, Xu Y, Wang Z. Icariin and its phosphorylated derivatives alleviate intestinal epithelial barrier disruption caused by enterotoxigenic Escherichia coli through modulate p38 MAPK in vivo and in vitro. FASEB j 2020;34:1783-801. [DOI: 10.1096/fj.201902265r] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Nowak JK, Szymańska CJ, Walkowiak J. Differential correlation network analysis of rectal transcriptomes reveals cystic fibrosis-related disturbance. Pharmacogenomics 2022. [PMID: 35189732 DOI: 10.2217/pgs-2021-0138] [Reference Citation Analysis]
9 Chunxi L, Haiyue L, Yanxia L, Jianbing P, Jin S. The Gut Microbiota and Respiratory Diseases: New Evidence. J Immunol Res 2020;2020:2340670. [PMID: 32802893 DOI: 10.1155/2020/2340670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Iorio A, Biazzo M, Gardini S, Muda AO, Perno CF, Dallapiccola B, Putignani L. Cross-correlation of virome-bacteriome-host-metabolome to study respiratory health. Trends Microbiol 2021:S0966-842X(21)00122-0. [PMID: 34052095 DOI: 10.1016/j.tim.2021.04.011] [Reference Citation Analysis]
11 Lazzarotto ES, Vasco JFM, Führ F, Riedi CA, Filho NAR. Systematic review on fecal calprotectin in cystic fibrosis. J Pediatr (Rio J) 2022:S0021-7557(22)00045-6. [PMID: 35523321 DOI: 10.1016/j.jped.2022.01.006] [Reference Citation Analysis]
12 CisarÒ F, Pizzol A, Rigazio C, Calvo PL. Fecal calprotectin in the pediatric population: a 2020 update. Minerva Pediatr 2020;72:514-22. [PMID: 32731735 DOI: 10.23736/S0026-4946.20.06002-8] [Reference Citation Analysis]
13 Xiong W, Ma H, Zhang Z, Jin M, Wang J, Xu Y, Wang Z. The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal epithelial cells injury. Biomed Pharmacother 2019;118:109246. [PMID: 31387006 DOI: 10.1016/j.biopha.2019.109246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Marsh R, Gavillet H, Hanson L, Ng C, Mitchell-Whyte M, Major G, Smyth AR, Rivett D, van der Gast C. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis. J Cyst Fibros 2021:S1569-1993(21)02155-X. [PMID: 34895838 DOI: 10.1016/j.jcf.2021.11.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Loman BR, Shrestha CL, Thompson R, Groner JA, Mejias A, Ruoff KL, O'Toole GA, Bailey MT, Kopp BT. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis. Pediatr Pulmonol 2020;55:1661-70. [PMID: 32275127 DOI: 10.1002/ppul.24766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhang D, Li S, Wang N, Tan HY, Zhang Z, Feng Y. The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases. Front Microbiol 2020;11:301. [PMID: 32158441 DOI: 10.3389/fmicb.2020.00301] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 33.0] [Reference Citation Analysis]
17 Karb DB, Cummings LC. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis. Curr Gastroenterol Rep 2021;23:17. [PMID: 34448955 DOI: 10.1007/s11894-021-00817-2] [Reference Citation Analysis]
18 Marlicz W, Koulaouzidis A. Small Bowel-Key Player in Health and Disease. J Clin Med 2019;8:E1748. [PMID: 31640212 DOI: 10.3390/jcm8101748] [Reference Citation Analysis]
19 Wang K, Qiu L, Zhu J, Sun Q, Qu W, Yu Y, Zhao Z, Yu Y, Shao G. Environmental contaminant BPA causes intestinal damage by disrupting cellular repair and injury homeostasis in vivo and in vitro. Biomed Pharmacother 2021;137:111270. [PMID: 33485121 DOI: 10.1016/j.biopha.2021.111270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Antosca KM, Chernikova DA, Price CE, Ruoff KL, Li K, Guill MF, Sontag NR, Morrison HG, Hao S, Drumm ML, MacKenzie TA, Dorman DB, Feenan LM, Williams MA, Dessaint J, Yuan IH, Aldrich BJ, Moulton LA, Ting L, Martinez-Del Campo A, Stewart EJ, Karagas MR, O'Toole GA, Madan JC. Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth. J Bacteriol 2019;201:e00274-19. [PMID: 31209076 DOI: 10.1128/JB.00274-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
21 Henen S, Denton C, Teckman J, Borowitz D, Patel D. Review of Gastrointestinal Motility in Cystic Fibrosis. J Cyst Fibros 2021;20:578-85. [PMID: 34147362 DOI: 10.1016/j.jcf.2021.05.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]